Tilray Brands (TLRY) to Report Q1 FY2025 Results October 10thTilray Brands Inc. (NASDAQ: NASDAQ:TLRY ), a global lifestyle and consumer packaged goods giant, is set to announce its Q1 Fiscal Year 2025 financial results on October 10, 2024. As the market eagerly anticipates the latest earnings report, let's dive into the company's recent performance, its strategic acquisition moves, and the stock's technical outlook, which offer both opportunities and potential risks for investors.
Overview
Tilray (NASDAQ: NASDAQ:TLRY ) has been making waves in both the cannabis and beverage industries, diversifying its portfolio and expanding its reach globally. Most notably, Tilray has completed the acquisition of Atwater Brewery from Molson Coors Beverage Company, further cementing its position in the craft beer industry. The acquisition adds Atwater Brewery, a historic Michigan-based craft brewery, to Tilray's growing list of premium brands, which includes SweetWater Brewing Company, Montauk Brewing Company, and more.
According to Tilray’s CEO, Irwin D. Simon, this acquisition enhances the company's presence in the Great Lakes region and strengthens its distribution channels. Tilray aims to leverage its resources to grow Atwater’s brand and introduce its signature brews to more beer enthusiasts across the U.S.
Financially, Tilray has shown strong revenue growth, reporting a 25.80% increase in revenue for FY2024, bringing in $788.94 million compared to $627.12 million the previous year. However, challenges persist on the profitability front, as the company posted losses of -$244.98 million, which, while substantial, are an 83.14% improvement compared to its previous year’s loss. This signals Tilray is making efforts to reduce its financial burden, though it has not yet reached profitability.
Analyst Sentiment and Stock Price Forecast
The average analyst sentiment for Tilray Brands’ stock is “Hold,” with a 12-month price target of $2.00. Currently trading at $1.70, this represents an expected 17.65% upside, a modest gain but potentially compelling for those seeking short- to medium-term investment opportunities.
It’s worth noting that Tilray (NASDAQ: NASDAQ:TLRY ) operates in an industry marked by volatility, as it juggles both the cannabis and consumer packaged goods markets. This makes its future growth trajectory dependent on various regulatory developments and the company’s ability to continue expanding into new markets and sectors.
Technical Analysis: Key Levels to Watch
From a technical perspective, NASDAQ:TLRY has seen a modest recovery, trading up 1.18% in premarket trading on Friday. The stock had previously been in a downward trend, but recent price action signals a potential shift.
Relative Strength Index (RSI) Currently sits at 45.58, the RSI indicates that the stock is neither overbought nor oversold. This suggests that while there’s some weakness, it also provides an opportunity for investors to capitalize on potential upside if a breakout occurs.
Support and Resistance Levels: Tilray's stock finds support at $1.50. Should the stock dip below this level, we may see a return to bearish momentum. Conversely, resistance at $2.00 serves as the next key level to break. If the stock can break through this resistance, it may attract new momentum traders and long-term investors, pushing it higher.
While the stock has recently bounced off support, the overall trend remains weak. Investors should closely monitor the stock’s movement approaching its Q1 results, as a move above or below the critical $1.50 support could signal further action.
Upcoming Earnings & Potential Catalysts
With the Q1 FY2025 earnings release scheduled for October 10, 2024, investors will be watching for several key metrics:
Revenue growth, particularly how the Atwater Brewery acquisition has impacted the top line.
Cost reduction efforts, as Tilray continues to narrow its losses.
Any updates on expansion plans, particularly in the cannabis market, which could provide a catalyst for stock price appreciation.
Additionally, Tilray’s diverse portfolio in cannabis, beverages, and consumer packaged goods offers multiple streams of revenue, which provides a level of insulation against market-specific headwinds. However, its success in achieving profitability and growing margins will remain critical for future stock price appreciation.
Conclusion: Opportunity With Caution
Tilray Brands (NASDAQ: NASDAQ:TLRY ) presents an interesting investment case with its significant growth potential driven by acquisitions and a diversified product line. However, the company is still facing financial hurdles, and its stock reflects ongoing volatility in the broader cannabis and consumer goods sectors.
For short-term traders, the current technical setup offers an opportunity to capitalize on a breakout above $2.00 or a potential pullback to the $1.50 support level. Long-term investors should focus on the company’s Q1 earnings and any signals that point toward sustained revenue growth and eventual profitability.
While Tilray’s stock is currently rated a Hold by analysts, its acquisition strategy and diversified portfolio position it as a potential turnaround candidate, making it a stock worth watching closely as Q1 results are unveiled.
Tilrayinc
Tilray: Finally arrived 🧳Two weeks ago, Tilray took heart and jumped into the turquoise zone between $1.46 and $2.27, leaving a visible gap on its way. Near the bottom of this zone, the share could establish the low of wave II in white by now, meaning that soon, the bulls should take over. We expect Tilray to develop enough upwards momentum to leave the turquoise zone on the northern side via wave (1) in magenta, taking a first step in the direction of the resistance at $5.12.
Tilray: Wait and See… 😌After initially spurring the downwards movement so commendably from the high of wave (4) in magenta, Tilray has been relaxing in a sidewards movement since December. However, there is yet some work to be done! We expect the share to drop a bit deeper still to finish wave II in gray, whose low should then form the basis for a fresh upwards movement. Wave (1) in magenta should carry the course above the resistance at $5.12 eventually and even the subsequent counter movement should peter out above this mark.
Tilray: Take Root 🌱Tilray has been developing some vibrant saplings, but the share shouldn’t forget to take root. We expect the course to extend below the support at $2.43 to plant wave II in gray. Then, Tilray should sprout upwards again, climbing back above $2.43 and growing further above the resistance at $5.12 as well. There, the course should complete wave (1) in magenta, before wave (2) in magenta should bring it back towards $5.12. However, there’s a 33% chance that wave alt. II could already be potted, which would be confirmed by the stock directly sprawling above the resistance at $5.12.
Tilray at support? Tilray
Short Term
We look to Buy at 3.18 (stop at 2.94)
We look to buy dips. There is scope for mild selling at the open but losses should be limited. A higher correction is expected. Expect trading to remain mixed and volatile. Previous support located at 3.120.
Our profit targets will be 3.74 and 3.99
Resistance: 3.75 / 4.00 / 5.15
Support: 3.20 / 3.00 / 2.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Tilray fighting back? Tilray
Short Term
We look to Buy at 3.09 (stop at 2.91)
We look to buy dips. Trading volume is increasing. There is scope for mild selling at the open but losses should be limited. Expect trading to remain mixed and volatile. Previous support located at 3.10.
Our profit targets will be 3.72 and 3.99
Resistance: 3.72 / 4.00 / 5.15
Support: 3.10 / 3.00 / 2.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
No rest for Tilray?Tilray
Short Term - We look to Sell at 5.33 (stop at 5.87)
Our outlook is bullish. A mild correction has been posted from yesterdays high, this is seen as a retest of the breakout level. The hourly chart technicals suggests further upside before the downtrend returns. The bias is still for lower levels and we look for any gains to be limited.
Our profit targets will be 3.92 and 3.18
Resistance: 5.50 / 8.50 / 15.00
Support: 4.00 / 3.00 / 2.00
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
Tell Ray to...I mean Tilray...Tilray Brands, Inc. NASDAQ:TLRY
Tell Ray to...I mean Tilray... okay, okay, okay. Tilray got himself in a descending triangle. My question to you is-Will Tilray get up and leave or will he fall down to his knees?
Well, I've cooked up an answer of my own after analyzing the information he provided on the daily chart. My findings are recorded below.
Pattern Identified- A descending triangle was identified on the daily chart for TLRY.
www.tradingview.com
Position Explained-Bullish divergence on the daily time frame. TLRY is currently in a downward trend. However, it is in a buy zone. Both the RSI and OBV indicators are pointing up at time of this post (after market hours 28 April 2022).
Peace and Prosperity,
Al
*******This is not financial advice.**************This is not financial advice.**************This is not financial advice.*******
Tilray HUGE VolumeTilray - Short Term - We look to Buy at 7.44 (stop at 6.71)
We look to buy dips. Trading volume is increasing. Previous resistance at 7.20 now becomes support. Last week Marabuzo is located at 8.56. Traded to the highest level in 70 weeks.
Our profit targets will be 9.82 and 10.30
Resistance: 10.00 / 13.50 / 22.00
Support: 7.20 / 5.00 / 2.50
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
TLRY: Time to get high?Just bought Tilray🌿 stocks @ 12.22, currently at trendlines & previous significant high confluence. Price needs to break up the red falling wedge. Target 122 which means 10x.
The blue uptrendline on log scale (imo false break down) and also higher volume this year shown below:
Please like👍, comment🗣️, follow me✒️, enjoy📺!
Disclaimer: I'm not financial advisor. This is not a financial advice. Do your own due dilingence.
NASDAQ:TLRY
TSX:TLRY
CAPITALCOM:TLRY
FTX:TLRYUSD
SIX:2HQ
NEO:TLRY
SWB:2HQ
XETR:2HQ
FWB:2HQ
MUN:2HQ
HAM:2HQ
HAN:2HQ
BER:2HQ
FTX:TLRY0924
NASDAQ:NDAQ
OANDA:NAS100USD
CURRENCYCOM:US100
TLRY Daily TimeframeSNIPER STRATEGY
This magical strategy works like a clock on almost any charts
Although I have to say it can’t predict pullbacks, so I do not suggest this strategy for leverage trading.
It will not give you the whole wave like any other strategy out there but it will give you huge part of the wave.
The best timeframe for this strategy is Daily, Weekly and Monthly however it can work any timeframe above three minutes.
Start believing in this strategy because it will reward believers with huge profit.
There is a lot more about this strategy.
It can predict and also it can give you almost exact buy or sell time on the spot.
I am developing it even more so stay tuned and start to follow me for more signals and forecasts.
TILRAY SHORT TERM OPPORTUNITY Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
Second asset of the cannabis sector analyzed. Bullish divergence on the daily timeframe flanked by a double top that heralds a probable bullish bottom. Target price $ 17 - $ 21. Take into account the riskiness of the sector when managing this asset. Plenty of room for maneuver for various investment strategies.
TILRAY SQUEEZE MAY BE COMING FASTER THAN YOU THINK In my first ever post in tradingview on 15May'21 when cought the falling knife at the exact bottom at $13.41 gave you also the weekly prediction until next May 2022 when I expect Tilray to be above $120 and most probably next stop somewhere between the $121-$153 price range (unless ofcourse EU takes steps for legalization also hence next parabolic arc will be to above $240 and towards new all time high).
In addition to the above I posted a couple of days later (when tilray at $15.01) a daily prediction until end November / Beg December 2021 where I expect Tilray to try to break the 52 week hanging man's high of $67 intraday 10FEB ($77 premarket 11FEB).
However seems to me that the anticipated squeeze will take place by next month and Tilray will break the February high by the end of July'21.
ALL IN
Tilray Given Up All Gains, Time to BuyThe potential for huge growth in cannabis companies is obvious. The spike we have seen in the past week has retraced almost all the way back to where it started, this offers a great chance to re-enter longs. The spike may have been caused by the Reddit craze nonsense which explains the big dump as well but this is still a good trade/investment.
I would like to see the price stabilise in the current area and confirm that the support here will hold as it has been very volatile. If it does hold here and show that it will rise then the previous high is a good target, around $64. If it breaks this resistance then a target of $115 can be next, this is 0.382 Fibonacci retracement from the all time high to the low. If you are looking at this as an investment there is no telling how high it could go.
TLRY Tilray Fibonacci Retracement completedTILRAY is also following the cannabis rally, even though the fundamentals aren`t there:
891.954M MARKET CAP and Net Income (FY) -321.169M. :)
So be careful with this one. It`s not life VFF (by the way, a great stock).
Tilray engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids.
If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.